BRIEF-Cipher Pharmaceuticals Q3 Adjusted EBITDA USD 7.237 Million Vs. IBES Estimate USD 7.61 Million
Nov 12 (Reuters) - Cipher Pharmaceuticals Q3 EBITDA USD 11.416 million.
Related stories
BoE's Pill Says Pressure to Return Inflation to 2% Is Probably Heightened
M impact | FX | Nov 14, 2026, 08:16 AM UTC
US Dollar Edges Higher Against Canadian Dollar
The US dollar climbed slightly against Canada's currency.
M impact | FX | Nov 13, 2026, 06:38 PM UTC
Dollar Hits One-Year Highs as Fed Tightening Risks Rise, Convera Says
Convera says the dollar has reached one-year highs as risks of Fed tightening rise.
M impact | FX | Nov 13, 2026, 02:07 PM UTC
Dollar Set for Best Week in Two Months as Yen Nears 160
The dollar held near 19-month highs and was set for its biggest weekly rise in two months. U.S. yields rose as bets on a larger rate hike increased, while the yen hovered around 16
M impact | FX | Nov 13, 2026, 12:51 PM UTC
Chilean Peso Falls 0.58%, Weakens Past 1,000 per Dollar
The peso weakened past 1,000 per U.S. dollar for the first time since January 2025.
M impact | FX | Nov 13, 2026, 12:27 PM UTC
Dollar Hits 19-Month High as Fed Rate-Hike Bets Firm
The dollar rises to a 19-month high against a basket of currencies as markets increase bets on another Federal Reserve rate hike in December, including the possibility of a 50-basi
M impact | FX | Nov 13, 2026, 11:13 AM UTC